Cargando…

Treatment utilization and treatment barriers in individuals with body dysmorphic disorder

BACKGROUND: Although effective treatments are available, most individuals with body dysmorphic disorder (BDD) do not receive an appropriate diagnosis or treatment. We aimed to examine treatment utilization and barriers to treatment, and to identify associated socio-demographic and clinical character...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulte, Johanna, Schulz, Claudia, Wilhelm, Sabine, Buhlmann, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027080/
https://www.ncbi.nlm.nih.gov/pubmed/32070300
http://dx.doi.org/10.1186/s12888-020-02489-0
_version_ 1783498795235934208
author Schulte, Johanna
Schulz, Claudia
Wilhelm, Sabine
Buhlmann, Ulrike
author_facet Schulte, Johanna
Schulz, Claudia
Wilhelm, Sabine
Buhlmann, Ulrike
author_sort Schulte, Johanna
collection PubMed
description BACKGROUND: Although effective treatments are available, most individuals with body dysmorphic disorder (BDD) do not receive an appropriate diagnosis or treatment. We aimed to examine treatment utilization and barriers to treatment, and to identify associated socio-demographic and clinical characteristics. METHODS: German individuals completed an online self-report survey of appearance concerns. A sample of N = 429 individuals met criteria for BDD. We examined the frequency of treatment utilization and barriers, analyzed comparisons between treated and untreated individuals and assessed the relationships of socio-demographic and clinical features with mental health treatment utilization and treatment barriers, respectively. RESULTS: Only 15.2% of the individuals with BDD had been diagnosed with BDD, and lifetime rates of mental health treatment were low (39.9%). Individuals endorsed multiple barriers to mental health treatment, especially shame, low perceived need and a preference for cosmetic and medical treatments. Associated features were identified, including age, a BDD diagnosis, body dysmorphic symptom severity, a likely major depressive disorder, prior cosmetic surgery, and insight. CONCLUSIONS: The results of this largest study to date highlight that BDD is still underrecognized and undertreated even in a country with extensive mental health care and few financial barriers. We discuss modifiable factors and strategies to foster awareness of BDD in sufferers and professionals to improve treatment dissemination and to reduce treatment barriers.
format Online
Article
Text
id pubmed-7027080
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70270802020-02-24 Treatment utilization and treatment barriers in individuals with body dysmorphic disorder Schulte, Johanna Schulz, Claudia Wilhelm, Sabine Buhlmann, Ulrike BMC Psychiatry Research Article BACKGROUND: Although effective treatments are available, most individuals with body dysmorphic disorder (BDD) do not receive an appropriate diagnosis or treatment. We aimed to examine treatment utilization and barriers to treatment, and to identify associated socio-demographic and clinical characteristics. METHODS: German individuals completed an online self-report survey of appearance concerns. A sample of N = 429 individuals met criteria for BDD. We examined the frequency of treatment utilization and barriers, analyzed comparisons between treated and untreated individuals and assessed the relationships of socio-demographic and clinical features with mental health treatment utilization and treatment barriers, respectively. RESULTS: Only 15.2% of the individuals with BDD had been diagnosed with BDD, and lifetime rates of mental health treatment were low (39.9%). Individuals endorsed multiple barriers to mental health treatment, especially shame, low perceived need and a preference for cosmetic and medical treatments. Associated features were identified, including age, a BDD diagnosis, body dysmorphic symptom severity, a likely major depressive disorder, prior cosmetic surgery, and insight. CONCLUSIONS: The results of this largest study to date highlight that BDD is still underrecognized and undertreated even in a country with extensive mental health care and few financial barriers. We discuss modifiable factors and strategies to foster awareness of BDD in sufferers and professionals to improve treatment dissemination and to reduce treatment barriers. BioMed Central 2020-02-18 /pmc/articles/PMC7027080/ /pubmed/32070300 http://dx.doi.org/10.1186/s12888-020-02489-0 Text en © The Author(s) 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Schulte, Johanna
Schulz, Claudia
Wilhelm, Sabine
Buhlmann, Ulrike
Treatment utilization and treatment barriers in individuals with body dysmorphic disorder
title Treatment utilization and treatment barriers in individuals with body dysmorphic disorder
title_full Treatment utilization and treatment barriers in individuals with body dysmorphic disorder
title_fullStr Treatment utilization and treatment barriers in individuals with body dysmorphic disorder
title_full_unstemmed Treatment utilization and treatment barriers in individuals with body dysmorphic disorder
title_short Treatment utilization and treatment barriers in individuals with body dysmorphic disorder
title_sort treatment utilization and treatment barriers in individuals with body dysmorphic disorder
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027080/
https://www.ncbi.nlm.nih.gov/pubmed/32070300
http://dx.doi.org/10.1186/s12888-020-02489-0
work_keys_str_mv AT schultejohanna treatmentutilizationandtreatmentbarriersinindividualswithbodydysmorphicdisorder
AT schulzclaudia treatmentutilizationandtreatmentbarriersinindividualswithbodydysmorphicdisorder
AT wilhelmsabine treatmentutilizationandtreatmentbarriersinindividualswithbodydysmorphicdisorder
AT buhlmannulrike treatmentutilizationandtreatmentbarriersinindividualswithbodydysmorphicdisorder